Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2004, Vol. 103, No. 5, pp. 1653-1661.
Prepublished online as a Blood First Edition Paper on October 30, 2003; DOI 10.1182/blood-2003-04-1148.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-04-1148v1
103/5/1653    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kopp, C. W
Right arrow Articles by Minar, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kopp, C. W
Right arrow Articles by Minar, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted April 14, 2003
Accepted October 16, 2003

Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity

Christoph W Kopp*, Thomas Hoelzenbein, Sabine Steiner, Rodrig Marculescu, Helga Bergmeister, Daniela Seidinger, Isabella Mosberger, Christoph Kaun, Manfred Cejna, Reinhard Horvat, Johann Wojta, Gerald Maurer, Bernd R Binder, Johannes M Breuss, Rupert C Ecker, Rainer de Martin, and Erich Minar

Division of Angiology, University of Vienna Medical School, Vienna, Austria
Division of Cardiology, University of Vienna Medical School, Vienna, Austria
Department of Vascular Surgery, University of Vienna Medical School, Vienna, Austria
Department of Biomedical Research, University of Vienna Medical School, Vienna, Austria
Department of Angiography and Interventional Radiology, University of Vienna Medical School, Vienna, Austria
Department of Pathology, University of Vienna Medical School, Vienna, Austria
Department of Vascular Biology and Thrombosis Research, University of Vienna Medical School, Vienna, Austria
Laboratory Medicine, University of Vienna Medical School, Vienna, Austria

* Corresponding author; email: christoph.kopp{at}univie.ac.at.

Activation of inflammatory and procoagulant mechanisms is thought to contribute significantly to the initiation of restenosis, a common complication after balloon angioplasty of obstructed arteries. During this process, expression of tissue factor (TF) represents one of the major physiologic triggers of coagulation that result in thrombus formation and the generation of additional signals leading to vascular smooth muscle cell (VSMC) proliferation and migration. In this study, we have investigated by which mechanisms inhibition of coagulation at an early stage through overexpression of tissue factor pathway inhibitor (TFPI), an endogenous inhibitor of TF, might reduce restenosis. In a rabbit femoral artery model, percutaneous delivery of TFPI using a recombinant adenoviral vector resulted in a significant reduction of the intima to media ratio 21 days after injury. When investigating several markers of inflammation and coagulation, we found reduced neointimal expression of monocyte chemoattractant protein-1, lesional monocyte infiltration, expression of vascular TF and matrix metalloproteinase-2 and -9. Moreover, overexpression of TFPI suppressed the autocrine release of PDGF-BB, MCP-1 and MMP-2 in response to factor VIIa and Xa from VSMC in vitro and inhibited monocyte TF-activity. These results suggest that TFPI exerts its action in vivo not only thorough thrombotic, but also non-thrombotic mechanisms.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Wang, J. Zhang, G. Spinetti, L.-Q. Jiang, R. Monticone, D. Zhao, L. Cheng, M. Krawczyk, M. Talan, G. Pintus, et al.
Angiotensin II Activates Matrix Metalloproteinase Type II and Mimics Age-Associated Carotid Arterial Remodeling in Young Rats
Am. J. Pathol., November 1, 2005; 167(5): 1429 - 1442.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020